Corning (US) to merge laboratory testing business?
This article was originally published in Clinica
Corning (US) is reported to be in discussions with SmithKline Beecham (UK/US) and possibly other parties about the sale or merger of its laboratory services division, MetPath. A deal could be worth more than $1,000 million, the Wall Street Journal reports.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.